BASEL, Switzerland, February 8, 2011 / CNW Telbec / -- Neuro-Biotech Corporation (PINKSHEET: MRES) (OTCQB: MRES), having recently signed a Business Development Agreement with Russian based Credo-TM, who in turn had just finished negotiations for 1,000,000 Post Traumatic Stress Disorder (PTSD) test with their nation?s military forces to help with early detection of PTSD which is an ongoing concern for worldwide military forces.
Stress, as defined by Hans Selye in 1945, could be expressed in regards to active military people first as a physical stress - we know that active military people are trained to be able to physically react to specific situations. Second, it can be expressed as a mental stress - active military people are also well trained in regards to alertness, vigilance, attention or automatisms related to their equipments. Finally, it can also be expressed in the form of emotional stress - it is the link to work with PTSD.
The human emotional memory is the basis of PTSD. In fact, the brain is used to receive all kind of information through our five senses, to retain and integrate it, to remember and initiate the emotions through "FLASHBACKS". In PTSD, such emotional information is so strong that it is impossible to forget it. However, it is possible to manage with it through recognition and acceptation process.
Some statistical data have clearly demonstrated that PTSD is present in the population. Thus, in USA, 5,600,000 people are affected, 1,600,000 in Germany, 1,200,000 in France, 1,600,000 in Egypt while in Switzerland, less than 200,000 people are affected by PTSD. These data are in good correlation with the WHO saying in its 2000?s Report that "Stress - a century?s disease".
